MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.
Huelse JM, Bhasin SS, Jacobsen KM, Yim J, Thomas BE, Branella GM, Bakhtiari M, Chimenti ML, Baxter TA, Raikar SS, Wang X, Frye SV, Henry CJ, Earp HS, Bhasin M, DeRyckere D, Graham DK.
Huelse JM, et al. Among authors: branella gm.
Leukemia. 2024 Sep 25. doi: 10.1038/s41375-024-02408-2. Online ahead of print.
Leukemia. 2024.
PMID: 39322710